Corrigendum to ‘Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database’ [The Breast 79 (2025) 103871] (The Breast (2025) 79, (S0960977624002029), (10.1016/j.breast.2024.103871))

Keiko Miyazato, Hiroshi Ohtsu, Akihiko Shimomura, Naohiro Yonemoto, Chikako Shimizu, Kazuhiro Sase, Shinichiro Ueda*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The authors regret that they have identified a few minor errors. Abstract correction: Sentence 9 “CMP_PSM than INT_PSM” was corrected to “INT_PSM than CMP_PSM” and the entire sentence was corrected to “The cumulative incidence of CTR-CVT was significantly higher in INT_PSM than CMP_PSM (log-rank test, P = .0096)”. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number103894
JournalBreast
Volume80
DOIs
StatePublished - 2025/04

ASJC Scopus subject areas

  • Surgery
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database’ [The Breast 79 (2025) 103871] (The Breast (2025) 79, (S0960977624002029), (10.1016/j.breast.2024.103871))'. Together they form a unique fingerprint.

Cite this